Liquid Crystal Microdomains Detect Endotoxin Amid Masking Agents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current endotoxin detection methods, such as the LAL assay, are affected by divalent cations, non-ionic surfactants, chelating agents, buffers, proteins, and nucleic acids, leading to inaccurate results and low endotoxin recovery, particularly in biopharmaceutical samples.
Innovation Solution
A liquid crystal-based system utilizing micrometer-sized droplets with point defects that remain accurate in the presence of masking agents, including non-ionic surfactants, chelating agents, divalent cations, proteins, and nucleic acids, by detecting configurational changes in the liquid crystals, which are not influenced by these agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If LAL-based assays are used for endotoxin detection, then sensitivity to endotoxin is achieved, but accuracy is reduced in the presence of masking agents such as divalent cations, non-ionic surfactants, chelating agents, buffers, proteins, and nucleic acids
Solution Approach 1:
The patent introduces an intermediary substance that specifically binds to endotoxin and triggers a detectable signal, bypassing the masking agents' interference with the traditional LAL assay mechanism. This intermediary approach allows endotoxin detection without direct reliance on the LAL reagent's interaction with endotoxin in the presence of masking agents.
Solution Approach 2:
The patent replaces the biochemical LAL assay mechanism with an alternative detection mechanism that is not susceptible to masking by divalent cations, non-ionic surfactants, chelating agents, buffers, proteins, and nucleic acids. This substitution eliminates the harmful interactions that plague traditional LAL-based methods.
2Reliability
If traditional LAL assays are performed, then endotoxin detection capability is provided, but reliability is compromised due to low endotoxin recovery in complex samples
Solution Approach 1:
The patent fundamentally changes the detection parameters and mechanism from traditional LAL-based biochemical reactions to an alternative system that measures endotoxin presence through different physical or chemical properties, thereby achieving reliable detection and quantification even in complex sample matrices where traditional methods fail to recover endotoxin accurately.
3Ease of operation
If LAL reagents are used, then endotoxin detection function is achieved, but device complexity and operational difficulty increase due to controlled storage conditions and skilled technician requirements
Solution Approach 1:
The patent employs disposable test elements or single-use detection systems that eliminate the need for complex storage conditions and repeated standardization procedures associated with LAL reagents. These simplified, potentially single-use components reduce operational complexity and eliminate the need for skilled technicians to manage reagent stability and batch variability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system effectively detects and quantifies endotoxin with high specificity and accuracy even in the presence of masking agents, overcoming the limitations of traditional assays by maintaining sensitivity and reliability across various sample conditions.
Implementation Method 1
a plurality of dispersed liquid crystal microdomains that are confined by an interface that generates one or more point defects in the liquid crystal microdomains
Implementation Method 2
The configurations of the liquid crystal microdomains can be determined using any suitable technique, including, but not limited to, optical and other imaging techniques
Data Source
AI summary
Devices and methods for using changes in the configuration of micrometer sized dispersed liquid crystal domains to detect or quantify analytes in a test sample, including endotoxin lipopolysaccharide (LPS), are disclosed. The test sample includes one or more potential masking agents, such as a non-ionic surfactant, a chelating agent, a divalent cation, a protein, or a nucleic acid, and may also include a buffer. The dispersed liquid crystal microdomains are exposed to the test sample, and any changes in the configuration in the liquid crystal microdomains, such as from the bipolar to radial configuration, are detected. Such changes in configuration signal the presence of analyte in the test sample, and the proportion of liquid crystal microdomains exhibiting the change in configuration is correlated with the quantity of analyte in the test sample.